AlphaNavi Pharma is a pioneering pharmaceutical company that aims to alleviate the suffering of patients experiencing pain and restore smiles to both patients and their families. Through cutting-edge research and development of innovative drugs, AlphaNavi Pharma is dedicated to freeing patients from the burden of pain. The company is actively engaged in the development of new drugs, with a focus on addressing the needs of patients suffering from pediatric limb pain attacks.

In exciting news, AlphaNavi Pharma recently announced the successful completion of a Series B round of fundraising, raising approximately 610 million yen. This funding will further support their efforts to develop groundbreaking medications. Committed to delivering new drugs to pain-stricken patients as quickly as possible, AlphaNavi Pharma is a forward-thinking, Kyoto-based start-up with a strong mission to revolutionize pain management